Previous 10 | Next 10 |
ANAHEIM, CA - ( NewMediaWire ) - December 07, 2022 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that it has partnered with Government Plus LLC, a leading provide...
Anaheim, CA - ( NewMediaWire ) - November 22, 2022 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that its board of directors has authorized the exploration o...
ANAHEIM, CA - ( NewMediaWire ) - November 15, 2022 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the third quarter ended September 30, 2...
BioCorRx press release ( OTCQB:BICX ): The Co. saw an increase in revenue in the third quarter of 2022 due to the increased number of patients treated at licensed clinics. Furthermore, they were pleased to see that membership/program fees also increased for the third quarter o...
Anaheim, California--(Newsfile Corp. - October 24, 2022) - BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that Lourdes Felix, Chief Executive Officer, Chief Financial Officer, a...
Anaheim, California--(Newsfile Corp. - October 20, 2022) - BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that Lourdes Felix, Chief Executive Officer, Chief Financial Officer, a...
ANAHEIM, CA, Oct. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that the last subject has been en...
ANAHEIM, CA - ( NewMediaWire ) - September 06, 2022 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that Lourdes Felix, CEO, CFO, and Director of BioCorRx, wi...
BioCorRx press release ( OTCQB:BICX ): Q2 GAAP EPS of -$0.19. Revenue of $16.01M (+1.8% Y/Y). For further details see: BioCorRx GAAP EPS of -$0.19, revenue of $16.01M
ANAHEIM, CA, Aug. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the second qu...
News, Short Squeeze, Breakout and More Instantly...
ANAHEIM, CA - ( NewMediaWire ) - May 16, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the three months ended March 31, 2024, and...
ANAHEIM, CA - ( NewMediaWire ) - April 03, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer of innovative treatment programs for substance use and related disorders, today announced that its subsidiary BioCorRx Pharmaceuticals Inc., a clinical-stage biopharmace...
ANAHEIM, CA - ( NewMediaWire ) - April 02, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the year ended December 31, 2023, and reported on...